This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Conjunctivitis, Allergic
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Phase 2b Evaluation of the Onset and Duration of ADX-102 Ophthalmic Drops (0.5% and 0.1%) Compared to Vehicle of ADX-102 Ophthalmic Drops in the Conjunctival Allergen Challenge (Ora-CAC®) Model of Acute Allergic Conjunctivitis.

Provided treatments

  • Drug: ADX-102 Ophthalmic Drops (0.5%)
  • Drug: ADX-102 Ophthalmic Drops (0.1%)
  • Drug: Vehicle of ADX-102 Ophthalmic Drops

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03012165. The sponsor of the trial is Aldeyra Therapeutics, Inc. and it is looking for 154 volunteers for the current phase.
Official trial title: